Please login to the form below

Not currently logged in

Chugai Pharma

This page shows the latest Chugai Pharma news and features for those working in and with pharma, biotech and healthcare.

Chugai soars on Roche buyout rumours

Chugai soars on Roche buyout rumours

Shares in Japanese pharma company Chugai are riding high amid growing speculation that Roche is poised to buy out the firm. ... price being bandied around, while others say Roche sees benefit on outright ownership of Chugai's portfolio.

Latest news

  • Chugai sets up antibody research company in Singapore

    Chugai Pharmabody Research will focus on generating new antibody drugs. Japanese pharma company Chugai is to set up a new research company based in Singapore. ... Chugai is putting 1.5m Singapore dollars (approximately $1.2m) into establishing the company

  • A rush for sweet success

    RYZOLTTM (Purdue Pharma). Chronic pain. US. Cyanocobalamin. PreHistin (Cobalis Corp). Allergy. ... The GLP-1 pipeline includes five phase III compounds – albiglutide (Syncria, GSK, Human Genome Sciences), LY2189265 (Eli Lilly), taspoglutide (Roche,

  • Chugai shares continue decline

    Shares in Rocheís Japanese subsidiary, Chugai, fall to a two-year low over concerns that the company may not meet earnings and sales targets. ... targets. Shares in Chugai fell 3.7 per cent (JPY 68) to bottom out at JPY 1, 750, the lowest since July 2005

  • Chugai profits may exceed forecast

    Chugai, the Japanese subsidiary of Swiss pharmaceutical company Roche, may exceed its own profits forecast. ... The analysts said that Epogin Q1 FY07 sales were not as badly affected by Nesp as Chugai first thought.

  • Teijin and Chugai to co-develop Ipsen's diabetes drug in Japan

    Teijin Pharma and Swiss-based Roche's Japanese subsidiary, Chugai Pharmaceutical, have announced a collaboration agreement to develop France-headquartered Ipsen's type 2 diabetes drug ITM-077 in Japan. ... Teijin and Chugai are now working together to

More from news
Approximately 1 fully matching, plus 6 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Chugai appoints Ruth Currie as MD of its UK business Chugai appoints Ruth Currie as MD of its UK business

    She replaces John Halls, who has been promoted. Chugai Pharmaceuticals has promoted Ruth Currie to managing director of its UK business. ... In her new role, Currie will oversee all UK commercial operations of Chugai, which has been a subsidiary of Roche

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Publicis Resolute

Publicis Resolute provides real-life practical solutions to your issues, without fuss or fluff. We are an experienced team with a...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...